TRAVELLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 360
EU - Europa 190
AS - Asia 43
OC - Oceania 2
Totale 595
Nazione #
US - Stati Uniti d'America 360
IE - Irlanda 123
IT - Italia 45
CN - Cina 21
SG - Singapore 20
BE - Belgio 9
DE - Germania 6
FI - Finlandia 4
AU - Australia 2
GB - Regno Unito 1
RU - Federazione Russa 1
SE - Svezia 1
TR - Turchia 1
TW - Taiwan 1
Totale 595
Città #
Dublin 123
Chandler 113
Ashburn 43
Boardman 41
Shanghai 17
Ann Arbor 15
Lawrence 15
Princeton 15
Singapore 12
Medford 11
Bolzaneto 9
Brussels 9
Wilmington 9
Milan 7
Chicago 6
Bossico 4
Helsinki 4
New York 4
Norwalk 4
Washington 4
Munich 3
Turin 3
Council Bluffs 2
Des Moines 2
Treviglio 2
Adelaide 1
Cambridge 1
Dallas 1
Guangzhou 1
Huizhou 1
Los Angeles 1
Moscow 1
Pinerolo 1
Rome 1
San Francisco 1
Seattle 1
Sydney 1
Taipei 1
Trezzano sul Naviglio 1
Totale 491
Nome #
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 54
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer 43
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 42
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 41
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 38
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 37
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 37
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 36
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 35
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 33
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents 32
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 28
Prostaglandin E2 and cancer: Insight into tumor progression and immunity 28
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 26
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers 25
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 23
Molecular regulations of circadian rhythm and implications for physiology and diseases 20
NAMPT: A pleiotropic modulator of monocytes and macrophages 18
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 14
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy 8
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 6
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 5
Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis 4
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer 4
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 3
eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage 3
Metabolic regulation of suppressive myeloid cells in cancer 3
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 3
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 3
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 3
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 3
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 3
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 3
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions 3
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 3
NAD depletion by FK866 induces autophagy 3
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 3
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 3
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies? 2
Characterization of NAD uptake in mammalian cells 2
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 2
Totale 685
Categoria #
all - tutte 4.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 11 0 6 0 1 1
2021/202297 1 1 1 0 2 1 0 7 5 1 10 68
2022/2023317 17 34 15 22 22 34 0 18 143 2 8 2
2023/2024108 9 13 6 11 17 29 0 20 1 1 0 1
2024/2025144 38 45 10 49 2 0 0 0 0 0 0 0
Totale 685